// App-Quantinova.ai

: The fibres study: a phase 3, non‐inferiority, randomized comparison of a new fibrinogen concentrate vs. cryoprecipitate for treating acquired hypofibrinogenemia in bleeding cardiac surgical patients

Researchers

Presenter

  • K. Karkouti

Principal Investigators

  • N/A

Medical Centers

  • Department of Anaesthesia, Toronto University Hospital,Toronto, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Carboxypeptidase B1

Drug/Treatment

  • Fibrinogen (IV)

  • Octafibrin

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Octapharma

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved